LifePoint Hospitals Upgraded to “Buy” at Ned Davis Research (LPNT)
LifePoint Hospitals (NASDAQ:LPNT) was upgraded by Ned Davis Research from a “neutral” rating to a “buy” rating in a research note issued on Monday, AnalystRatings.NET reports.
LifePoint Hospitals (NASDAQ:LPNT) traded up 0.12% during mid-day trading on Monday, hitting $56.16. 22,982 shares of the company’s stock traded hands. LifePoint Hospitals has a 52-week low of $40.58 and a 52-week high of $56.21. The stock has a 50-day moving average of $51.89 and a 200-day moving average of $49.30. The company has a market cap of $2.640 billion and a price-to-earnings ratio of 20.77.
LifePoint Hospitals (NASDAQ:LPNT) last announced its earnings results on Friday, October 25th. The company reported $0.68 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.66 by $0.02. The company had revenue of $899.70 million for the quarter, compared to the consensus estimate of $891.30 million. During the same quarter in the prior year, the company posted $0.39 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Analysts expect that LifePoint Hospitals will post $2.80 EPS for the current fiscal year.
LPNT has been the subject of a number of other recent research reports. Analysts at Mizuho raised their price target on shares of LifePoint Hospitals from $49.00 to $54.00 in a research note to investors on Tuesday, December 17th. They now have a “buy” rating on the stock. Separately, analysts at Deutsche Bank upgraded shares of LifePoint Hospitals from a “hold” rating to a “buy” rating in a research note to investors on Thursday, November 14th. They now have a $61.00 price target on the stock, up previously from $56.00. Finally, analysts at FBR & Co. initiated coverage on shares of LifePoint Hospitals in a research note to investors on Friday, November 8th. They set a “market perform” rating on the stock. One analyst has rated the stock with a sell rating, ten have given a hold rating and eight have given a buy rating to the stock. LifePoint Hospitals presently has an average rating of “Hold” and an average price target of $51.36.
LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.